# Vitalant – FDA Inspection, Aug 23, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/ac9566f8-0243-4802-a723-05d877396335
Source feed: FDA_Inspections

> FDA inspection 1100311 of Vitalant, August 23, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100311
- Company Name: Vitalant
- Inspection Date: 2019-08-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1281129 - 2025-09-04
- FDA Inspection 1193237 - 2022-12-01
- FDA Inspection 1106128 - 2019-06-28
- FDA Inspection 1102324 - 2019-06-28
- [FDA Inspection 962753 - 2016-03-04](https://www.keypedia.com/records/fda_inspections/vitalant/c70eb3df-7a17-4e7c-9b53-0a7f07573605)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amanda-b-vega/9629eae7-acd3-4d4a-b456-a9427b525efb)
- [Investigator](https://www.keypedia.com/people/carl-e-lovrich/28ad3898-eaac-4f07-8dc5-09bda890c63a)
- [Company Rep](https://www.keypedia.com/people/erika-m-wilkerson/cd1c299d-c827-4d52-8e2b-719989da9991)

Company: https://www.keypedia.com/companies/vitalant/4d5b6798-751c-4489-b957-3f93c0b86883

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d